-
Je něco špatně v tomto záznamu ?
Successful use of metronomic vinblastine and fluorothymidine pet imaging for the management of intramedullary spinal cord anaplastic oligoastrocytoma in a child
R. Demlova, K. Melicharkova, Z. Rehak, L. Kren, H. Oslejskova, J. Sterba,
Jazyk angličtina Země Kanada
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2006
Free Medical Journals
od 2006
PubMed Central
od 2006
Europe PubMed Central
od 2006
Open Access Digital Library
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2005
PubMed
25489269
DOI
10.3747/co.21.2147
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Children with high-grade glioma still have a poor prognosis despite the use of multimodal therapy including surgery, radiotherapy, and chemotherapy. New therapeutic strategies and methods evaluating such therapies are needed. OBSERVATION: Here we describe a child with anaplastic oligodendroglioma of the spinal cord who was unable to tolerate standard chemoradiotherapy and who had still-vital residual tumour during therapy. A good response was obtained with low-dose metronomic treatment containing vinblastine. The treatment was guided according to gradual response assessed using various positron-emission tomography tracers. CONCLUSIONS: Metronomic treatment guided by positron-emission tomography could be a reasonable option in some high-risk pediatric tumours.
Department of Nuclear Medicine Masaryk Memorial Cancer Institute Brno Czech Republic
Department of Pathology University Hospital Brno Brno Czech Republic
Department of Pediatric Neurology University Hospital Brno Brno Czech Republic
Department of Pediatric Oncology University Hospital Brno Brno Czech Republic
Department of Pharmacology Masaryk University School of Medicine Brno Czech Republic
Regional Center for Applied Molecular Oncology Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15008667
- 003
- CZ-PrNML
- 005
- 20210121105922.0
- 007
- ta
- 008
- 150305s2014 xxc f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3747/co.21.2147 $2 doi
- 035 __
- $a (PubMed)25489269
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxc
- 100 1_
- $a Demlova, R $u Department of Pharmacology, Masaryk University School of Medicine, Brno, Czech Republic. ; Regional Center for Applied Molecular Oncology, Brno, Czech Republic.
- 245 10
- $a Successful use of metronomic vinblastine and fluorothymidine pet imaging for the management of intramedullary spinal cord anaplastic oligoastrocytoma in a child / $c R. Demlova, K. Melicharkova, Z. Rehak, L. Kren, H. Oslejskova, J. Sterba,
- 520 9_
- $a BACKGROUND: Children with high-grade glioma still have a poor prognosis despite the use of multimodal therapy including surgery, radiotherapy, and chemotherapy. New therapeutic strategies and methods evaluating such therapies are needed. OBSERVATION: Here we describe a child with anaplastic oligodendroglioma of the spinal cord who was unable to tolerate standard chemoradiotherapy and who had still-vital residual tumour during therapy. A good response was obtained with low-dose metronomic treatment containing vinblastine. The treatment was guided according to gradual response assessed using various positron-emission tomography tracers. CONCLUSIONS: Metronomic treatment guided by positron-emission tomography could be a reasonable option in some high-risk pediatric tumours.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Melicharkova, K $u Department of Pediatric Oncology, University Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Rehak, Z $u Department of Nuclear Medicine, Masaryk Memorial Cancer Institute, Brno, Czech Republic. ; Regional Center for Applied Molecular Oncology, Brno, Czech Republic.
- 700 1_
- $a Kren, L $u Department of Pathology, University Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Oslejskova, H $u Department of Pediatric Neurology, University Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Sterba, J $u Regional Center for Applied Molecular Oncology, Brno, Czech Republic. ; Department of Pediatric Oncology, University Hospital Brno, Brno, Czech Republic.
- 773 0_
- $w MED00165427 $t Current oncology (Toronto, Ont.) $x 1198-0052 $g Roč. 21, č. 6 (2014), s. e790-3
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25489269 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150305 $b ABA008
- 991 __
- $a 20210121105921 $b ABA008
- 999 __
- $a ind $b bmc $g 1065940 $s 891467
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 21 $c 6 $d e790-3 $i 1198-0052 $m Current oncology $n Curr. oncol. $x MED00165427
- LZP __
- $a Pubmed-20150305